Partner Headlines - CRL

  1. Charles River Laboratories, AstraZeneca Renew Strategic Partnership ...

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. US Stock Futures Jump Ahead Of Jobless Claims Data

    Benzinga
  4. Carl Appoints Rick Sanderson to the Board of Directors

    GuruFocus
  5. Earnings Scheduled For February 10, 2015

    Benzinga
  6. Top 4 NYSE Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  7. John Rogers Comments on Charles River Laboratories Intl Inc

    GuruFocus
  8. John Rogers' Ariel Fund Second Quarter 2014 Commentary

    GuruFocus
  9. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD
  10. Morgan Stanley Feels Confidence in Charles River Laboratories ...

    Benzinga
  11. CHARLES RIVER LABS

    IBD
  12. Earnings Scheduled For February 11, 2014

    Benzinga
  13. Parexel Plunges After 3 CROs Report Earnings

    IBD
  14. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD
  15. Medical Research Firms Tap Drug Development Trend

    IBD
  16. Medical Research Firms Tap Drug Development Trend

    IBD
  17. Earnings Scheduled For February 13, 2013

    Benzinga
  18. Robert Olstein's Largest New Stock Picks

    GuruFocus
  19. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles ...

    Benzinga
  20. Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE

    GuruFocus
  21. Charles River Laboratories International Inc (CRL) Corp. ...

    GuruFocus
  22. Charles River Labs Closes Purchase of Majority Ownership of Vital ...

    Benzinga
  23. UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight ...

    Benzinga
  24. Mid-Afternoon Market Update: Bernanke Press Conference Leads ...

    Benzinga
  25. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga
  26. UPDATE: ISI Group Cuts PT to $39 on Charles River Laboratories ...

    Benzinga
  27. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ...

    Benzinga
  28. Charles River Laboratories International Reports Operating Results ...

    GuruFocus
  29. UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT ...

    Benzinga
  30. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ...

    Benzinga
  31. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  32. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  33. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  34. Charles River Opens New Biomedical Diagnostic Facility

    Benzinga
  35. Charles River Acquires Accugenix

    Benzinga
  36. Charles River Laboratories International Reports Operating Results ...

    GuruFocus
  37. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  38. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  39. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  40. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  41. Charles River Laboratories International (CRL) Chairman, President ...

    GuruFocus
  42. Health Care Sector Wrap

    FoxBusiness
  43. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  44. Charles River Labs

    IBD
  45. Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy"

    GuruFocus
  46. Stocks I Can Buy Much Cheaper Than Halvorsen Did

    GuruFocus
  47. Ken Heebner Top Holdings: AAPL Is a Buy at $380

    GuruFocus
  48. Benzinga's M&A Chatter for Tuesday January 10, 2012

    Benzinga
  49. Charles River rises on sale talk

    IBD
  50. JP Morgan Reiterates BioMimetic Therapeutics Neutral

    Benzinga
  51. Citigroup Lowers PT on Charles River Laboratories to $31

    Benzinga
  52. UPDATE: Deutsche Bank Lowers PT on Charles River Laboratories ...

    Benzinga
  53. Deutsche Bank Maintains Hold After Charles River Releases 2012 ...

    Benzinga
  54. Notable Call Options Activity in Charles River Laboratories

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!